Literature DB >> 12821938

VDUP1 upregulated by TGF-beta1 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression.

Seung Hyun Han1, Jun Ho Jeon, Hyang Ran Ju, Uhee Jung, Kun Young Kim, Hyang Sook Yoo, Young Ho Lee, Kyu Sang Song, Ho Myeung Hwang, Yoon Sook Na, Young Yang, Kee Nyung Lee, Inpyo Choi.   

Abstract

Vitamin D(3) upregulated protein 1 (VDUP1) is a 1,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) upregulated protein, and it is induced by various stresses. In human tumor tissues, VDUP1 expression was downregulated. Upon stimulation by growth-inhibitory signals such as TGF-beta1 and 1,25(OH)(2)D(3), its expression was rapidly upregulated as the cell growth was retarded. The transfection of VDUP1 in tumor cells reduced cell growth. The VDUP1 expression was also increased when the cell-cycle progression was arrested. Transfection of VDUP1 induced cell-cycle arrest at the G0/G1 phase, indicating that VDUP1 possesses a tumor-suppressive activity. In addition, it was found that VDUP1 interacted with promyelocytic leukemia zinc-finger, Fanconi anemia zinc-finger, and histone deacetylase 1, which are known to be transcriptional corepressors. VDUP1 itself suppressed IL-3 receptor and cyclin A2 promoter activity. Taken together, these results suggest that VDUP1 is a novel antitumor gene which forms a transcriptional repressor complex.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12821938     DOI: 10.1038/sj.onc.1206610

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  87 in total

1.  Evidence for premature aging due to oxidative stress in iPSCs from Cockayne syndrome.

Authors:  Luciana Nogueira de Sousa Andrade; Jason L Nathanson; Gene W Yeo; Carlos Frederico Martins Menck; Alysson Renato Muotri
Journal:  Hum Mol Genet       Date:  2012-06-01       Impact factor: 6.150

Review 2.  Physiological insights gained from gene expression analysis in obesity and diabetes.

Authors:  Mark P Keller; Alan D Attie
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

3.  A global genomic view on LNX siRNA-mediated cell cycle arrest.

Authors:  Dan Zheng; Shaohua Gu; Yao Li; Chaoneng Ji; Yi Xie; Yumin Mao
Journal:  Mol Biol Rep       Date:  2010-11-21       Impact factor: 2.316

4.  Dormant but migratory tumour cells in desmoplastic stroma of invasive ductal carcinomas.

Authors:  Vanisri Raviraj; Hui Zhang; Hsin-ya Chien; Louise Cole; Erik W Thompson; Lilian Soon
Journal:  Clin Exp Metastasis       Date:  2012-01-22       Impact factor: 5.150

5.  High glucose-induced thioredoxin-interacting protein in renal proximal tubule cells is independent of transforming growth factor-beta1.

Authors:  Weier Qi; Xinming Chen; Richard E Gilbert; Yuan Zhang; Mark Waltham; Maria Schache; Darren J Kelly; Carol A Pollock
Journal:  Am J Pathol       Date:  2007-08-03       Impact factor: 4.307

6.  The microarray gene profiling analysis of glioblastoma cancer cells reveals genes affected by FAK inhibitor Y15 and combination of Y15 and temozolomide.

Authors:  Grace Huang; Baotran Ho; Jeffrey Conroy; Song Liu; Hu Qiang; Vita Golubovskaya
Journal:  Anticancer Agents Med Chem       Date:  2014-01       Impact factor: 2.505

7.  AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1.

Authors:  Ning Wu; Bin Zheng; Adam Shaywitz; Yossi Dagon; Christine Tower; Gary Bellinger; Che-Hung Shen; Jennifer Wen; John Asara; Timothy E McGraw; Barbara B Kahn; Lewis C Cantley
Journal:  Mol Cell       Date:  2013-02-28       Impact factor: 17.970

8.  Biology of SNU cell lines.

Authors:  Ja-Lok Ku; Jae-Gahb Park
Journal:  Cancer Res Treat       Date:  2005-02-28       Impact factor: 4.679

9.  Intracellular shuttling and mitochondrial function of thioredoxin-interacting protein.

Authors:  Geetu Saxena; Junqin Chen; Anath Shalev
Journal:  J Biol Chem       Date:  2009-12-03       Impact factor: 5.157

10.  Clinical Significance of the Thioredoxin System and Thioredoxin-Domain-Containing Protein Family in Hepatocellular Carcinoma.

Authors:  Sang Yeon Cho; Sungha Kim; Mi-Ju Son; Woo Sun Rou; Seok Hyun Kim; Hyuk Soo Eun; Byung Seok Lee
Journal:  Dig Dis Sci       Date:  2018-10-04       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.